1
|
Doda V, Kumar A, Schwartz S. Utilization of Head Imaging in Children and Adolescents With First-Episode Psychosis: A Retrospective Analysis. Cureus 2024; 16:e65675. [PMID: 39205719 PMCID: PMC11355483 DOI: 10.7759/cureus.65675] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/29/2024] [Indexed: 09/04/2024] Open
Abstract
Background Psychotic disorders are commonly diagnosed in the mid-20s but symptoms often emerge earlier during late teenage years to mid-20s. Notably, studies have shown that psychotic symptoms can also affect younger individuals, with a higher prevalence among preteens than teens. Head imaging via computed tomography (CT) or magnetic resonance imaging (MRI) can be performed to rule out non-psychiatric causes of psychotic symptoms in this population but may pose additional risks and financial burdens. Practice patterns vary regarding when to utilize head imaging in pediatric patients with first-episode psychosis (FEP). The purpose of this study is to better understand the use of head imaging in pediatric FEP and associated patient characteristics. Methods A retrospective cohort study was performed. Eligible patients were <18 years of age with an encounter documented between 2013 and 2023 where a diagnosis code for psychosis was first applied. Medical records were manually reviewed if head imaging was performed during the index encounter or within one month. Descriptive statistics were used to report the study population demographics. Independent t-testing was used to compare characteristics between patients who did and did not receive head imaging. Results A total of 113 patients met the inclusion criteria for the study, of which 12 (10.6%) received head imaging within the specified timeframe. All received CT criteria head scans, and a significantly higher proportion were African American or Black when compared to those who did not receive head imaging (10/12 (83.3%) vs. 53/101 (52.5%) p=0.023). None of the imaging tests performed yielded significant neurological findings that suggested an underlying pathology for psychosis. Conclusions Head imaging was rarely utilized for the initial assessment of pediatric FEP in this study. When it was used, CT head scans were the modality of choice but did not yield any remarkable findings to suggest a non-psychiatric cause of psychotic symptoms. This adds to the body of evidence supporting a conservative approach when considering head imaging in pediatric FEP.
Collapse
Affiliation(s)
- Vandana Doda
- Psychiatry, Moses Cone Hospital, Greensboro, USA
| | | | - Shaina Schwartz
- Clinical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, USA
| |
Collapse
|
2
|
Wang Y, Zha H. Neuroimaging for differential diagnosis of transient neurological attacks. Brain Behav 2022; 12:e2780. [PMID: 36350080 PMCID: PMC9759151 DOI: 10.1002/brb3.2780] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Revised: 08/04/2022] [Accepted: 09/14/2022] [Indexed: 11/11/2022] Open
Abstract
BACKGROUND Rapid yet comprehensive neuroimaging protocols are required for patients with suspected acute stroke. However, stroke mimics can account for approximately one in five clinically diagnosed acute ischemic strokes and the rate of thrombolyzed mimics can be as high as 17%. Therefore, to accurately determine the diagnosis and differentiate mimics from true transient ischemic attacks, acute ischemic stroke is a challenge to every clinician. DISCUSSION Medical history and neurological examination, noncontract head computed tomography, and routine magnetic resonance imaging play important roles in the assessment and management of patients with transient neurological attacks in the emergency department. This review attempts to summarize how neuroimaging can be utilized to help differentiate the most common mimics from transient ischemic attack and acute ischemic stroke. CONCLUSION Although imaging can help direct critical triage decisions for intravenous thrombolysis or endovascular therapy, more detailed medical history and neurological examination are crucial for making a prompt and accurate diagnosis for transient neurological attack patients.
Collapse
Affiliation(s)
- Ying Wang
- Department of Neurology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Hao Zha
- Department of Reproductive and Genetics, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
| |
Collapse
|
3
|
Tadd K, Rego T, Gaillard F, Malpas CB, Walterfang M, Velakoulis D, Farrand S. Neuroimaging in the Acute Psychiatric Setting: Associations With Neuropsychiatric Risk Factors. J Neuropsychiatry Clin Neurosci 2022; 35:184-191. [PMID: 36128679 DOI: 10.1176/appi.neuropsych.21110269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE The appropriateness and clinical utility of neuroimaging in psychiatric populations has been long debated, and the ambiguity of guideline recommendations is well established. Most of the literature is focused on first-episode psychosis. The investigators aimed to review ordering practices and identify risk factors associated with neuroradiological MRI abnormalities and their clinical utility in a general psychiatric population. METHODS A retrospective file review was undertaken for 100 consecutive brain MRI scans for adult psychiatric inpatients who received scanning as part of their clinical care in an Australian hospital. RESULTS Brain MRI was abnormal in 79.0% of scans; in these cases, 72.2% of patients required further investigation or follow-up, with 17.7% requiring urgent referral within days to weeks, despite only 3.7% of admitted patients undergoing MRI during the study period. Psychiatrically relevant abnormalities were found in 32.0% of scans. Abnormalities were more likely to be found in the presence of cognitive impairment, older age, and longer duration of psychiatric disorder. Psychiatrically relevant abnormalities had further associations with older age at onset of the psychiatric disorder and a weak association with abnormal neurological examination. Multiple indications for imaging were present in 57.0% of patients; the most common indications were physical, neurological, and cognitive abnormalities. CONCLUSIONS Brain MRI is a useful part of psychiatric management in the presence of certain neuropsychiatric risk factors. The present findings suggest that treating teams can judiciously tailor radiological investigations while limiting excessive imaging. Future research in larger cohorts across multiple centers may contribute to shaping more consistent neuroimaging guidelines in psychiatry.
Collapse
Affiliation(s)
- Katelyn Tadd
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| | - Thomas Rego
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| | - Frank Gaillard
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| | - Charles B Malpas
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| | - Mark Walterfang
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| | - Dennis Velakoulis
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| | - Sarah Farrand
- Mental Health Program, NorthWestern Mental Health (Tadd, Rego, Farrand) and Eastern Health (Tadd), Melbourne, Victoria, Australia; Department of Psychiatry (Rego), Faculty of Medicine, Dentistry and Health Sciences (Gaillard), and Melbourne School of Psychological Sciences (Malpas), University of Melbourne; Department of Radiology (Gaillard), Clinical Outcomes Research Unit, Department of Medicine (Malpas), Department of Neurology (Malpas), and Department of Neuropsychiatry (Walterfang, Velakoulis, Farrand), Royal Melbourne Hospital; Melbourne Neuropsychiatry Center, University of Melbourne and NorthWestern Mental Health (Walterfang, Velakoulis); Florey Institute of Neuroscience and Mental Health, Melbourne (Walterfang)
| |
Collapse
|
4
|
Letlotlo BL, Lumu LD, Moosa MYH, Jeenah FY. Clinical use of neuro-imaging in psychiatric patients at the Charlotte Maxeke Johannesburg Academic Hospital. S Afr J Psychiatr 2021; 27:1614. [PMID: 34192082 PMCID: PMC8182466 DOI: 10.4102/sajpsychiatry.v27i0.1614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Accepted: 03/07/2021] [Indexed: 11/30/2022] Open
Abstract
Background Neuro-imaging is relatively new in psychiatry. Although the actual role of neuro-imaging in psychiatry remains unclear, it is used to strengthen clinical evidence in making psychiatric diagnoses. Aim To analyse the records of inpatients referred for neuro-imaging (computerised tomography [CT] and/or magnetic resonance imaging [MRI] scans) to determine the proportion of abnormal neuro-imaging results and, if any, factors associated with abnormal neuro-imaging results. Setting This study was conducted at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) situated in Johannesburg, South Africa. Methods This was a quantitative retrospective record review. All adult psychiatric inpatients who had undergone a CT and/or MRI scan during 01 January 2014 to 31 December 2015 were included. Out-patients or patients admitted in the medical wards were excluded from the study. All neuro-imaging referrals were identified from hospital records and their demographics, scan characteristics and diagnoses were subsequently captured. Results A total of 1040 patients were admitted to the CMJAH psychiatric unit, of which 213 (20.5%) underwent neuro-imaging tests. Of the 213 scans performed, 74 were abnormal, representing a yield of 34.7%. The most common reported pathology was atrophy (n = 22, 29.7%). There was no statistically significant association between age group (χ2 = 3.9, p = 0.8), gender (χ2 = 1.3; p = 0.5), psychiatric diagnoses and abnormal scans. However, there were trends towards an association with comorbid HIV infection (χ2 = 3.476, p = 0.062) and comorbid substance abuse (χ2 = 2.286, p = 0.091). Conclusion This study supports the need for clear clinical indications to justify the cost-effective use of neuro-imaging in psychiatry. This study’s high yield of abnormal CT scans, although similar to other studies, advocates that HIV positive testing and the presence of focal neurological signs will improve the yield further.
Collapse
Affiliation(s)
- Bokang L Letlotlo
- Department of Psychiatry, Faculty of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Lavinia D Lumu
- Department of Psychiatry, Faculty of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Mahomed Y H Moosa
- Department of Psychiatry, Faculty of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Fatima Y Jeenah
- Department of Psychiatry, Faculty of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa
| |
Collapse
|